KAYLA BOSCO: Open Payments
NPI 1972109429 · PASCAGOULA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 19 payments from 10 companies in 2025. Trend: 2023 $408 · 2024 $385 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $147 |
| Renalytix AI, Inc. | 4 | $76 |
| Averitas Pharma Inc. | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Medtronic, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: KRYSTEXXA, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, QUTENZA, Kerendia, INCEPTIV, Veozah, Wegovy, JARDIANCE.
Industry payments across MS — which companies pay providers there.
